Filmed at the 2018 EACTS Annual Meeting in Milan, Italy, Jill Ley of California Pacific Medical Center in San Francisco, USA, moderates a discussion on evidence-based recommendations for movement following sternotomy.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Heart Failure
April 10, 2019
This is an educational video on the completion of a transaortic septal myectomy.
April 4, 2019
Carmelo Milano discusses left ventricular assist device destination therapy and the future perspectives of mechanical circulatory support.
March 31, 2019
In this state-of-the-art review review, the authors summarize current knowledge of anatomic, structural, metabolic, functional, and hemodynamic characteristics of the right ventricle (RV) in both health and disease. Highlights of this review are:
March 26, 2019
The investigators published the final analysis of the MOMENTUM 3 trial comparing the fully magnetically levitated centrifugal continuous-flow HeartMate 3 pump to the mechanical-bearing axial continuous-flow HeartMate II pump.
March 11, 2019
Find it here: The SCTS 2019 "Take on the Experts" Video Competition.
March 8, 2019
Patient Care and General Interest
The American Heart Association has released a scientific statement summarizing emerging knowledge about sensitization after heart transplant.
February 8, 2019
Patient Care and General Interest
February 7, 2019
In the February issue of The Annals, The Society of Thoracic Surgeons published the first annual report after the Interagency Registry for Mechanically Assisted Circulatory Support (Intermacs) joined the STS National Database in January 2018. This report summarizes the outcomes in patients (≥19 years of age) undergoing durable MCS implant b
February 5, 2019
In a letter to healthcare providers, the US FDA summarized a recent evaluation of a postapproval study of the Abiomed Impella RP system. In clinical trials, 73% of patients survived 30 days after device explant, hospital discharge, or to definitive intervention. In the postapproval study, just over 17% of patients met this goal.